Zimmerman-Federle H, Ren G, Dowling S, Warren C, Rusyniak D, Avera R
Drug Test Anal. 2024; 17(1):138-151.
PMID: 38584344
PMC: 11729250.
DOI: 10.1002/dta.3687.
Aldubayyan A, Castrignano E, Elliott S, Abbate V
Forensic Toxicol. 2024; 42(2):172-180.
PMID: 38554217
PMC: 11269387.
DOI: 10.1007/s11419-024-00684-2.
Aldubayyan A, Castrignano E, Elliott S, Abbate V
Forensic Toxicol. 2023; 41(1):81-93.
PMID: 36652059
PMC: 9849191.
DOI: 10.1007/s11419-022-00634-w.
Aldubayyan A, Castrignano E, Elliott S, Abbate V
Pharmaceuticals (Basel). 2022; 15(5).
PMID: 35631341
PMC: 9145040.
DOI: 10.3390/ph15050510.
Calvo-Castro J, Guirguis A, Samaras E, Zloh M, Kirton S, Stair J
RSC Adv. 2022; 8(56):31924-31933.
PMID: 35547469
PMC: 9085863.
DOI: 10.1039/c8ra05847d.
The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
Kolaczynska K, Thomann J, Hoener M, Liechti M
Int J Mol Sci. 2021; 22(15).
PMID: 34361040
PMC: 8348686.
DOI: 10.3390/ijms22158277.
A Scoping Review of Non-Medical and Extra-Medical Use of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs).
Brennan R, Wazaify M, Shawabkeh H, Boardley I, McVeigh J, Van Hout M
Drug Saf. 2021; 44(9):917-928.
PMID: 34331260
PMC: 8370940.
DOI: 10.1007/s40264-021-01085-9.
Identification and Analytical Characterization of a Novel Synthetic Cannabinoid-Type Substance in Herbal Material in Europe.
Tsochatzis E, Alberto Lopes J, Holland M, Reniero F, Palmieri G, Guillou C
Molecules. 2021; 26(4).
PMID: 33546439
PMC: 7913736.
DOI: 10.3390/molecules26040793.
The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
Brandt S, Walters H, Partilla J, Blough B, Kavanagh P, Baumann M
Psychopharmacology (Berl). 2020; 237(12):3703-3714.
PMID: 32875347
PMC: 7686291.
DOI: 10.1007/s00213-020-05648-z.
Gas Chromatography-Fourier Transform Infrared Spectroscopy for Unambiguous Determination of Illicit Drugs: A Proof of Concept.
Salerno T, Donato P, Frison G, Zamengo L, Mondello L
Front Chem. 2020; 8:624.
PMID: 32850646
PMC: 7396574.
DOI: 10.3389/fchem.2020.00624.
How to Study the Metabolism of New Psychoactive Substances for the Purpose of Toxicological Screenings-A Follow-Up Study Comparing Pooled Human Liver S9, HepaRG Cells, and Zebrafish Larvae.
Wagmann L, Frankenfeld F, Park Y, Herrmann J, Fischmann S, Westphal F
Front Chem. 2020; 8:539.
PMID: 32766204
PMC: 7380166.
DOI: 10.3389/fchem.2020.00539.
Differential activation of G protein-mediated signaling by synthetic cannabinoid receptor agonists.
Sachdev S, Banister S, Santiago M, Bladen C, Kassiou M, Connor M
Pharmacol Res Perspect. 2020; 8(2):e00566.
PMID: 32101383
PMC: 7043210.
DOI: 10.1002/prp2.566.
DARK Classics in Chemical Neuroscience: Aminorex Analogues.
Maier J, Mayer F, Brandt S, Sitte H
ACS Chem Neurosci. 2018; 9(10):2484-2502.
PMID: 30269490
PMC: 6287711.
DOI: 10.1021/acschemneuro.8b00415.
Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.
Guillou C, Reniero F, Lobo Vicente J, Holland M, Kolar K, Chassaigne H
Curr Pharm Biotechnol. 2018; 19(2):91-98.
PMID: 29792142
PMC: 6110040.
DOI: 10.2174/1389201019666180523122717.
Fluorinated phenmetrazine "legal highs" act as substrates for high-affinity monoamine transporters of the SLC6 family.
Mayer F, Burchardt N, Decker A, Partilla J, Li Y, McLaughlin G
Neuropharmacology. 2017; 134(Pt A):149-157.
PMID: 28988906
PMC: 7294773.
DOI: 10.1016/j.neuropharm.2017.10.006.
Pharmacological characterization of novel synthetic opioids (NSO) found in the recreational drug marketplace.
Baumann M, Majumdar S, Le Rouzic V, Hunkele A, Uprety R, Huang X
Neuropharmacology. 2017; 134(Pt A):101-107.
PMID: 28807672
PMC: 5809328.
DOI: 10.1016/j.neuropharm.2017.08.016.
Updating the list of known opioids through identification and characterization of the new opioid derivative 3,4-dichloro-N-(2-(diethylamino)cyclohexyl)-N-methylbenzamide (U-49900).
Fabregat-Safont D, Carbon X, Ventura M, Fornis I, Guillamon E, Sancho J
Sci Rep. 2017; 7(1):6338.
PMID: 28740128
PMC: 5524693.
DOI: 10.1038/s41598-017-06778-9.
Misuse of Novel Synthetic Opioids: A Deadly New Trend.
Prekupec M, Mansky P, Baumann M
J Addict Med. 2017; 11(4):256-265.
PMID: 28590391
PMC: 5537029.
DOI: 10.1097/ADM.0000000000000324.
Return of the lysergamides. Part IV: Analytical and pharmacological characterization of lysergic acid morpholide (LSM-775).
Brandt S, Kavanagh P, Twamley B, Westphal F, Elliott S, Wallach J
Drug Test Anal. 2017; 10(2):310-322.
PMID: 28585392
PMC: 6230476.
DOI: 10.1002/dta.2222.
Return of the lysergamides. Part III: Analytical characterization of N -ethyl-6-norlysergic acid diethylamide (ETH-LAD) and 1-propionyl ETH-LAD (1P-ETH-LAD).
Brandt S, Kavanagh P, Westphal F, Elliott S, Wallach J, Stratford A
Drug Test Anal. 2017; 9(10):1641-1649.
PMID: 28342178
PMC: 6230477.
DOI: 10.1002/dta.2196.
